Skip to main content
. 2021 Nov 11;61(7):2894–2904. doi: 10.1093/rheumatology/keab827

Fig. 3.


Fig. 3

Relationships between patient demographics and BCD in vitro

Relationships between rituximab-mediated BCD and age of patients with (A) RA and (B) SLE, and disease duration of patients with (C) RA and (D) SLE, and (E) serum C3 levels in patients with SLE. BCD: B cell depletion.